The global drug delivery devices market size was valued at USD 280.98 billion in 2024 and is projected to reach from USD ...

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

A couple of University of Nebraska professors have launched a startup company with the goal of bringing to market an ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Andrew Ratz, Ph.D., has joined the company as Senior Vice ...

A large number of drug carriers have been developed by scientists around the world, but many of these fail due to toxicity from materials that evoke an immune response. "At present, the challenges ...

The UK injectable drug delivery market is set to grow at 8.80% CAGR through 2034, driven by rising obesity rates and the approval of weight-loss injectable.

The Prosthetic Replacement of Ocular Surface Ecosystem was well-tolerated and appeared efficacious as a delivery system for ...